Dr. Abraham Katz, M.D

NPI: 1538279807
Total Payments
$12,480
2024 Payments
$2,195
Companies
23
Transactions
851
Medicare Patients
321
Medicare Billing
$69,390

Payment Breakdown by Category

Food & Beverage$11,914 (95.5%)
Education$566.16 (4.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $11,914 846 95.5%
Education $566.16 5 4.5%

Top Paying Companies

Company Total Records Latest Year
Sunovion Pharmaceuticals Inc. $2,528 202 $0 (2022)
Takeda Pharmaceuticals U.S.A., Inc. $1,469 124 $0 (2022)
Lundbeck LLC $1,353 127 $0 (2024)
Alkermes, Inc. $1,263 45 $0 (2024)
ITI, Inc. $1,229 51 $0 (2023)
Allergan, Inc. $765.32 92 $0 (2020)
Otsuka America Pharmaceutical, Inc. $740.53 67 $0 (2024)
Corium, LLC $656.87 26 $0 (2024)
ABBVIE INC. $318.85 23 $0 (2024)
Teva Pharmaceuticals USA, Inc. $313.03 9 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,195 92 Alkermes, Inc. ($543.28)
2023 $1,538 72 Alkermes, Inc. ($564.79)
2022 $920.49 60 Sunovion Pharmaceuticals Inc. ($419.76)
2021 $1,867 127 ITI, Inc. ($565.18)
2020 $1,260 67 Sunovion Pharmaceuticals Inc. ($413.71)
2019 $1,683 149 Sunovion Pharmaceuticals Inc. ($526.51)
2018 $1,562 157 Sunovion Pharmaceuticals Inc. ($483.48)
2017 $1,453 127 Lundbeck LLC ($330.96)

All Payment Transactions

851 individual payment records from CMS Open Payments — Page 1 of 35

Date Company Product Nature Form Amount Type
12/19/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $29.97 General
Category: CNS Stimulant for ADHD
12/17/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $19.45 General
Category: NEUROSCIENCE
12/09/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $12.06 General
Category: PSYCHIATRY
12/06/2024 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $14.21 General
Category: Neurology
12/03/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $21.88 General
Category: SCHIZOPHRENIA
12/03/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $11.80 General
Category: CNS
11/22/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $16.47 General
Category: PSYCHIATRY
11/14/2024 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Food and Beverage In-kind items and services $124.99 General
Category: CNS
11/13/2024 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $17.71 General
Category: Neurology
11/13/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $14.40 General
Category: SCHIZOPHRENIA
11/13/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $13.52 General
Category: PSYCHIATRY
11/13/2024 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $2.30 General
Category: Neurology
11/06/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $21.98 General
Category: CNS Stimulant for ADHD
11/06/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $2.02 General
Category: CNS Stimulant for ADHD
11/05/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $12.10 General
Category: PSYCHIATRY
11/04/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $7.61 General
Category: CNS
11/01/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $33.10 General
Category: CNS Stimulant for ADHD
10/30/2024 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $29.41 General
10/28/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $14.97 General
Category: PSYCHIATRY
10/25/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $14.31 General
Category: CNS
10/17/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Education In-kind items and services $27.27 General
Category: Psychiatry/Psychology
10/17/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $10.01 General
Category: PSYCHIATRY
10/16/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $15.00 General
Category: CNS Stimulant for ADHD
10/11/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $21.45 General
Category: CNS Stimulant for ADHD
10/10/2024 Teva Pharmaceuticals USA, Inc. Education In-kind items and services $111.49 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 78 227 $44,775 $19,690
2022 4 65 129 $25,200 $11,940
2021 4 96 244 $47,525 $21,424
2020 4 82 203 $39,675 $16,336
Total Patients
321
Total Services
803
Medicare Billing
$69,390
Procedure Codes
16

All Medicare Procedures & Services

16 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 19 65 $14,625 $6,055 41.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 20 46 $11,500 $5,344 46.5%
90836 Psychotherapy with evaluation and management visit, 45 minutes Office 2023 19 66 $9,900 $4,335 43.8%
90838 Psychotherapy with evaluation and management visit, 1 hour Office 2023 20 50 $8,750 $3,955 45.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 18 42 $9,450 $4,000 42.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 13 21 $5,250 $2,920 55.6%
90836 Psychotherapy with evaluation and management visit, 45 minutes Office 2022 18 42 $6,300 $2,835 45.0%
90838 Psychotherapy with evaluation and management visit, 1 hour Office 2022 16 24 $4,200 $2,185 52.0%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 23 81 $18,225 $7,531 41.3%
90836 Psychotherapy with evaluation and management visit, 45 minutes Office 2021 23 86 $12,900 $5,822 45.1%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 23 39 $9,750 $4,766 48.9%
90838 Psychotherapy with evaluation and management visit, 60 minutes Office 2021 27 38 $6,650 $3,306 49.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 23 77 $17,325 $6,280 36.2%
90838 Psychotherapy, 60 minutes Office 2020 22 46 $8,050 $4,132 51.3%
90836 Psychotherapy, 45 minutes Office 2020 19 57 $8,550 $3,965 46.4%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 18 23 $5,750 $1,959 34.1%

About Dr. Abraham Katz, M.D

Dr. Abraham Katz, M.D is a Psychiatry healthcare provider based in El Paso, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538279807.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abraham Katz, M.D has received a total of $12,480 in payments from pharmaceutical and medical device companies, with $2,195 received in 2024. These payments were reported across 851 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($11,914).

As a Medicare-enrolled provider, Katz has provided services to 321 Medicare beneficiaries, totaling 803 services with total Medicare billing of $69,390. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location El Paso, TX
  • Active Since 08/30/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1538279807

Products in Payments

  • LATUDA (Drug) $2,528
  • REXULTI (Drug) $1,317
  • CAPLYTA (Drug) $1,229
  • VRAYLAR (Drug) $1,044
  • TRINTELLIX (Drug) $1,038
  • ARISTADA (Drug) $780.84
  • Azstarys (Drug) $636.05
  • Trintellix (Drug) $621.94
  • VYVANSE (Drug) $582.98
  • LYBALVI (Drug) $447.07
  • FANAPT (Drug) $230.47
  • INGREZZA (Drug) $199.85
  • Dyanavel XR (Drug) $191.55
  • Vyvanse (Drug) $155.74
  • JORNAY PM (Drug) $143.40
  • QUILLIVANT XR (Drug) $125.93
  • MYDAYIS (Drug) $115.07
  • INVEGA SUSTENNA (Drug) $98.00
  • UZEDY (Drug) $62.55
  • BRINTELLIX (Drug) $61.04

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in El Paso